GW Pharmaceuticals EV/Sales
What is the EV/Sales of GW Pharmaceuticals?
The EV/Sales of GW Pharmaceuticals is 11.53
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with ev/sales similar to GW Pharmaceuticals
- Biolase Inc has EV/Sales of 11.50
- Witan Investment Trust Plc has EV/Sales of 11.51
- PIMCO Strategic Income Fund Inc has EV/Sales of 11.51
- Automotive Properties Real Estate Investment Trust has EV/Sales of 11.52
- Tai United has EV/Sales of 11.53
- Unum Therapeutics has EV/Sales of 11.53
- GW Pharmaceuticals has EV/Sales of 11.53
- Leucrotta Exploration has EV/Sales of 11.53
- Gabelli Healthcare & WellnessRx Trust has EV/Sales of 11.53
- Pro Fin Capital Services has EV/Sales of 11.53
- Chinlink International has EV/Sales of 11.55
- Paisalo Digital has EV/Sales of 11.56
- Hindustan Copper has EV/Sales of 11.56